Legionnaires' disease, caused by Legionella bacteria, is a severe form of pneumonia that is often misdiagnosed due to a lack of clinical awareness and the difficulty in detecting the bacteria. Legionella, gram-negative bacteria found in freshwater, were first isolated in the 1940s and later classified as a genus in 1979 after an outbreak linked to the American Legion. These bacteria are intracellular parasites of freshwater protozoa and can cause respiratory disease when inhaled or aspirated. Legionnaires' disease presents as a severe multisystem illness, while Pontiac fever is a self-limited flu-like illness. Diagnosis is challenging due to the similarity of symptoms with other pneumonias, but appropriate microbiologic testing is crucial. Legionella is commonly found in human-made aquatic environments, and outbreaks are often linked to factors like warm water temperatures and the presence of protozoa. Legionella thrives in biofilms within building water systems, making these environments a significant reservoir. The bacteria can survive in biofilms and are more easily detected from biofilm samples than from flowing water. Studies suggest that biofilms may support the survival and multiplication of Legionella outside host cells, which has implications for control strategies. The life cycle of Legionella involves intracellular multiplication within host cells, and recent studies have identified virulence factors and molecular mechanisms involved in infection. Legionella can infect both protozoa and mammalian cells, and the bacteria's ability to survive and multiply intracellularly is a key aspect of its pathogenesis. Diagnosis of Legionella involves various methods, including culture, direct fluorescent antibody (DFA) detection, serologic tests, and urine antigen detection. Culture remains the gold standard, but DFA and urine antigen tests are also widely used. Serologic tests, such as the indirect immunofluorescence assay (IFA), are important for detecting antibodies to Legionella, although cross-reactions with other bacteria can occur. Urine antigen detection is a rapid and specific method for diagnosing Legionnaires' disease, particularly for L. pneumophila serogroup 1. However, it may miss cases caused by other serogroups. The use of urine antigen testing has increased in the United States, leading to more cases being diagnosed, but it may also result in missed cases of other Legionella species. Overall, Legionnaires' disease is a preventable illness, and control strategies focus on managing water systems to prevent bacterial growth. Understanding the microbial ecology, pathogenesis, and diagnostic methods is essential for effective prevention and treatment of Legionnaires' disease.Legionnaires' disease, caused by Legionella bacteria, is a severe form of pneumonia that is often misdiagnosed due to a lack of clinical awareness and the difficulty in detecting the bacteria. Legionella, gram-negative bacteria found in freshwater, were first isolated in the 1940s and later classified as a genus in 1979 after an outbreak linked to the American Legion. These bacteria are intracellular parasites of freshwater protozoa and can cause respiratory disease when inhaled or aspirated. Legionnaires' disease presents as a severe multisystem illness, while Pontiac fever is a self-limited flu-like illness. Diagnosis is challenging due to the similarity of symptoms with other pneumonias, but appropriate microbiologic testing is crucial. Legionella is commonly found in human-made aquatic environments, and outbreaks are often linked to factors like warm water temperatures and the presence of protozoa. Legionella thrives in biofilms within building water systems, making these environments a significant reservoir. The bacteria can survive in biofilms and are more easily detected from biofilm samples than from flowing water. Studies suggest that biofilms may support the survival and multiplication of Legionella outside host cells, which has implications for control strategies. The life cycle of Legionella involves intracellular multiplication within host cells, and recent studies have identified virulence factors and molecular mechanisms involved in infection. Legionella can infect both protozoa and mammalian cells, and the bacteria's ability to survive and multiply intracellularly is a key aspect of its pathogenesis. Diagnosis of Legionella involves various methods, including culture, direct fluorescent antibody (DFA) detection, serologic tests, and urine antigen detection. Culture remains the gold standard, but DFA and urine antigen tests are also widely used. Serologic tests, such as the indirect immunofluorescence assay (IFA), are important for detecting antibodies to Legionella, although cross-reactions with other bacteria can occur. Urine antigen detection is a rapid and specific method for diagnosing Legionnaires' disease, particularly for L. pneumophila serogroup 1. However, it may miss cases caused by other serogroups. The use of urine antigen testing has increased in the United States, leading to more cases being diagnosed, but it may also result in missed cases of other Legionella species. Overall, Legionnaires' disease is a preventable illness, and control strategies focus on managing water systems to prevent bacterial growth. Understanding the microbial ecology, pathogenesis, and diagnostic methods is essential for effective prevention and treatment of Legionnaires' disease.